When new education-related information on hepatitis C becomes available this blog provides readers with background information, links and a few tips for navigating the website.
A few days ago IAS-USA published a new CME webcast, "Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes, discussing the rapid advances in HCV treatment." headed up by the one and only Douglas T Dieterich MD, Susanna Naggie MD, John Webb Ward MD, George M. Shaw MD, PhD, FACP, Kimberly A Workowski MD, FACP, FIDSA, Michael S Saag MD, Jennifer J Kiser PharmD, and Kenneth E Sherman MD, PhD.
The live activity includes case studies discussing the following topics; who should begin therapy, treatment regimens, resistance, current direct-acting antivirals, investigational direct-acting antivirals and interferon alfa-free regimens, effects of HCV on the liver, drug-drug interactions, and managing the adverse-effects of therapy.
Naviatgating The CME Webcast
Links are provided below to each presentation.
*The webcast will take only a few minutes to load, its worth the wait. Each presentation is approximately thirty minutes to an hour.
No registration is required
1-Click on a presentation below - after landing on the index page click "Watch the Webcast"
2-Scroll to the bottom of the page and click on “I have read these instructions and understand them,” to begin activity.
Presentations
Susanna Naggie MD
John Webb Ward MD
George M. Shaw MD, PhD
Douglas T Dieterich MD, FACP
Susanna Naggie MD
Kimberly A Workowski MD, FACP, FIDSA
Michael S Saag MD
Jennifer J Kiser PharmD
No comments:
Post a Comment